Aptamers: An emerging class of molecules that rival antibodies in diagnostics

Clinical Chemistry

Volumn 45, Issue 9, 1999, Pages 1628-1650

  Jayasena, Sumedha D ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; APTAMER; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CAPILLARY ELECTROPHORESIS; FLOW CYTOMETRY; FLUORESCENCE POLARIZATION; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; SENSOR;

HARNESS;

EID: 0032860385     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.9.1628     Document Type: Article

References (181)

1. Schultz PG, Lerner RA, Benkovic SJ. Catalytic antibodies. Chem Eng News 1990;68:26-40.
2. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990;249:505-10.
3. Ellington AD, Szostak J. In vitro selection of RNA molecules that bind specific ligands. Nature 1990;346:818-22.
4. Charlton J, Sennello J, Smith D. In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase. Chem Biol 1997;4:809-16.
5. Yallow RS, Berson SA. Assay of plasma insulin in human subjects by immunological methods. Nature 1959;185:1648-9.
6. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:496-7.
7. Clark PM, Price CP. Removal of interference by immunoglobulins in an enzyme-amplified immunoassay for thyrotropin in serum. Clin Chem 1987;33:414.
8. Cook DB, Self CH. Monoclonal antibodies in diagnostic immunoassays. In: Ritter MA, Ladyman HM, eds. Monoclonal antibodies. Cambridge, UK: Cambridge University Press, 1995:180-208.
9. Boulianne GL, Hozumi N, Shulman MJ, Production of functional chimeric mouse/human antibody. Nature 1984;312:643-6.
10. Vaughan T, Osbourn JK, Tempest PR. Human antibodies by design. Nat Biotechnol 1998;16:535-9.
11. Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science 1990;249:386-90.
12. Cwirla SE, Peters EA, Barrett RW, Dower WJ. Peptides on phage: a vast library of peptides for identifying ligands. Proc Natl Acad Sci U S A 1990;87:6378-82.
13. He M, Taussig MJ. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 1997;25:5132-4.
14. Hanes J, Jermutus L, Weber-Bornhauser S, Bosshard HR, Pluckthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc Natl Acad Sci U S A 1998;95:14130-5.
15. Roberts RW, Szostak JW. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc Natl Acad Sci U S A 1997;94:12297-302.
16. Kirkham PM, Neri D, Winter G. Towards the design of an antibody that recognizes a given protein epitope. J Mol Biol 1999;285:909-15.
17. Van Ness J. Laemmli UK, Pettijohn DE. Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins. Proc Natl Acad Sci U S A 1984; 81:7897-901.
18. Tuerk C, Eddy S, Parma D, Gold L. Autogenous translational operator recognized by bacteriophage T4 DNA polymerase. J Mol Biol 1990;213:749-61.
19. Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, et al. Potent 2′-amino-2′deoxypyrimidine RNA inhibitors of basic fibro-blast growth factor. Biochemistry 1995;34:11363-72.
20. Tasset DM, Kubik MF, Steiner W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol 1997; 272:688-98.
21. Jenison RD, Jennings SD, Walker DW, Bargatze RF, Parma D. Oligonucleotide inhibitors of P-selectin-dependent neutrophilplatelet adhesion. Antisense Nucleic Acid Drug Day 1998;8:265-79.
22. Kubik MF, Stephens AW, Schneider D, Marlar RA, Tasset D. High-affinity RNA ligands to human α-thrombin. Nucleic Acids Res 1994:22:2619-26.
23. Lin Y, Padmapriya A, Morden KM. Jayasena SD. Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition. Proc Natl Acad Sci U S A 1995;92:11044-8.
24. Cox JC, Rudolph P, Ellington AD. Automated RNA selection. Biotechnol Prog 1998;14:845-50.
25. Jenison RD, Gill SC, Pardi A, Polisky B. High-resolution molecular discrimination by RNA. Science 1994;263:1425-9.
26. Haller AA, Sarnow P. In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci U S A 1997;94:8521-6.
27. Sassanfar M, Szostak JW. An RNA motif that binds ATP. Nature 1993:364:550-3.
28. Mannironi C, Nardo AD, Fruscoloni P, Tocchini-Valentini GP. In vitro selection of dopamine RNA ligands. Biochemistry 1997:36:9726-34.
29. Geiger A, Burgstaller P, von der Eltz H, Roeder A, Famulok M. RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res 1996; 24:1029-36.
30. Uhlmann E, Peyman A. Antisense oligonucleotides: a new therapeutic principle. Chem Rev 1990;90:543-84.
31. Agrawal S. Antisense oligonucleotides: towards clinical trials. Trends Biotechnol 1996:14:376-87.
32. Stein CA. Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides. Chem Biol 1996;3:319-23.
33. Stein CA. Phosphorothioate antisense: question of specificity. Trends Biotechnol 1996;14:147-9.
34. Hobbs J, Sternbach H, Sprinzl M, Eckstein F. Polynucleotides containing 2′-amino-2′-deoxyribose and 2′-axido-2′-deoxyribose. Biochemistry 1973;12:5138-45.
35. Pieken WA, Olsen DB, Benseler F, Aurup H, Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science 1991;253:314-7.
36. Heidenreich O, Eckstein F. Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J Biol Chem 1992;267:1904-9.
37. Lin Y, Qiu Q, Gill SC, Jayasena SD. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res 1994;22:5229-34.
38. Wiegand TW, Williams PB, Dreskin SC, Jouvin M-H, Kinet J-P, Tasset D. High-affinity oligonucleotide ligands to human IgE inhibit binding to Fce receptor I. J Immunol 1996;157:231-8.
39. Pagratis NC, Bell C, Chang Y-F, Jennings S. Fitzwater T, Jellinek D, et al. Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nat Biotechnol 1997;15:68-73.
40. Davis KA. Lin Y, Abrams B, Jayasena SD. Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res 1998;26:3915-24.
41. Piccirilli JA, Krauch T, Moroney SE, Benner SA. Enzymatic incorporation of a new base pair into DNA and RNA extends the genetic alphabet. Nature 1990;343:33-7.
42. Bain DJ, Switzer C, Chamberlin AR, Benner SA. Ribosome-mediated incorporation of a non-standard amino acid into a peptide through expansion of the genetic code. Nature 1992; 356:537-9.
43. 6-(6-aminohexyl)isoguanosine, into RNA. J Am Chem Sec 1993;115:4461-7.
44. Schweitzer BA, Fool ET. Hydrophobic, non-hydrogen-bonding bases and base pairs in DNA. J Am Chem Sec 1995;117:1863-72.
45. Guckian KM, Krugh TR, Kool ET. Efficient replication between non-hydrogen-bonded nucleotide shape analogues. Nat Struct Biol 1998;5:950-9.
46. Latham JA, Johnson R, Toole JJ. The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2′-deoxyuridine. Nucleic Acids Res 1994; 22:2817-22.
47. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992;355:564-6.
48. Dewey TM, Mundt AA, Crouch GJ, Zyzniewski MC, Eaton BE. New uridine derivatives for systematic evolution of RNA ligands by exponential enrichment. J Am Chem Sec 1995;117:8474-5.
49. Eaton BE. The joys of in vitro selection: chemically dressing oligonucleotides to satiate protein targets. Curr Opin Chem Biol 1997;1:10-6.
50. Liu J, Sodeoka M, Lane WS, Verdine GL. Evidence for a non-α-helical DNA-binding motif in the Rel homology region. Proc Natl Acad Sci U S A 1994;91:908-12.
51. Blatter EE, Ebright YW, Ebright RH. Identification of an amino acid-base contact in the GCN4-DNA complex by bromouracil-mediated photocrosslinking. Nature 1992;359:650-2.
52. Hicke BJ, Willis MC, Koch TH, Cech TR. Telomeric protein-DNA point contacts identified by photo-cross-linking using 5-bromode-oxyuridine. Biochemistry 1994;33:3364-73.
53. Willis MC, Hicke BJ, Uhlenbeck OC, Cech TR, Koch TH. Photocrosslinking of 5-iodouracil-substituted RNA and DNA to proteins. Science 1993;262:1255-7.
54. Meisenheimer KM, Meisenheimer PL, Willis MC, Koch TH. High yield photocrosslinking of a 5-iodocytidine (IC) substituted RNA to its associated protein. Nucleic Acids Res 1996;24:981-2.
55. Jensen KB, Atkinson BL, Willis MC, Koch TH, Gold L Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type i Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci U S A 1995;92;12220-4.
56. Willis MC, LeCuyer KA, Meisenheimer KM, Uhlenbeck OC, Koch TH. An RNA-protein contact determined by 5-bromouridine substitution, photocrosslinking and sequencing. Nucleic Acids Res 1994;22:4947-52.
57. Eaton BE, Gold L, Hicke BJ, Janjic N, Jucker FM, Sebesta DP, et al. Post-SELEX combinatorial optimization of aptamers. Bioorg Med Chem 1997;5:1087-96.
58. Gold L, Allen P, Binkley J, Brown D, Schneider B, Yasset D, et al. RNA: the shape of things to come. In: Gesteland R, Atkins J, eds. The RNA world. Plainview, NY: Cold Spring Harbor Laboratory Press, 1993:497-509.
59. Gold L, Polisky B. Uhlenbeck O, Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem 1995;64:763-97.
60. Ciesiolka J, Yarus M. Small RNA-divalent domains. RNA 1996; 2:785-93.
61. 2+3-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair. RNA 1997;3:1289-300.
62. Ellington AD, Szostak JW. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992;355:850-2.
63. Connell GJ, Illangesekare M, Yarus M. Three small ribooligo-nucleotides with specific arginine sites. Biochemistry 1993;32:5497-502.
64. Famulok M. Molecular recognition of amino acids by RNA-aptamers: an L-citrulline binding RNA motif and its evolution into an L-arginine binder. J Am Chem Sec 1994;116:1698-706.
65. Harada K, Frankel AD. Identification of two novel arginine binding DNAs. EMBO J 1995;14:5798-811.
66. Lauhon CT, Szostak JW. RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Sec 1995:117:1246-57.
67. Burgstaller P, Famulok M. Isolation of RNA aptamers for biological cofactors by in vitro selection. Angew Chem 1994;33:1084-7.
68. Lorsch JR, Szostak JW. In vitro selection of RNA aptamers specific for cyanocobalamin. Biochemistry 1994;33:973-82.
69. Burke DH, Gold L. RNA aptamers to the adenosine moiety of S-adenosyl methionine: structural inferences from variations on a theme and the reproducibility of SELEX. Nucleic Acids Res 1997;25:2020-4.
70. Wilson C, Nix J, Szostak J. Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot. Biochemistry 1998;37:14410-9.
71. Wang Y, Rando RR. Specific binding of aminoglycoside antibiotics to RNA. Chem Biol 1995;2:281-90.
72. Wallis MG. Ahsen Uv, Schroeder R, Famulok M. A novel RNA motif for neomycin recognition. Chem Biol 1995;2:543-52.
73. Lato SM, Boles AR, Ellington AD. In vitro selection of RNA lectins: using combinatorial chemistry to interpret ribozyme evolution. Chem Biol 1995;2:291-303.
74. Wang Y, Killian J, Hamasaki K, Rando RR. RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. Biochemistry 1996;35:12338-46.
75. Wallis MG, Streicher B, Wank H, Ahsen U, Clodi E, Wallace ST, et al. In vitro selection of a viomycin-binding RNA pseudoknot. Chem Biol 1997;4:357-66.
76. Wallace ST, Schroeder R. In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics. RNA 1998;4:112-23.
77. Kiga D, Futamura Y, Sakamoto K, Yokoyama S. An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine recognition. Nucleic Acids Res 1998;26:1755-60.
78. Huizenga DE, Szostak JW. A DNA aptamer that binds adenosine and ATP. Biochemistry 1995;34:656-65.
79. Nieuwlandt D, Wecker M, Gold L. In vitro selection of RNA ligands to substance P. Biochemistry 1995;34:5651-9.
80. Williams KP, Liu X-H, Schumacher TNM, Lin HY, Ausiello DA, Kim PS, et al. Bioactive and nuclease-resistant L-DNA ligand of vasopressin. Proc Natl Acad Sci U S A 1997;94:11285-90.
81. Tuerk C, MacDougal S, Gold L. RNA pseudoknots that inhibit HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A 1992;89:6988-92.
82. Chen H, McBroom DG, Zhu Y-Q, Gold L, North TW. Inhibitory RNA ligands to reverse transcriptase from feline immunodeficiency virus. Biochemistry 1996;35:6923-30.
83. Chen H, Gold L. Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity. Biochemistry 1994;33:8746-56.
84. Dang C, Jayasena SD. Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR. J Mol Biol 1996;264:268-78.
85. 2). J Med Chem 1998;41:778-86.
86. Jellinek D, Lynott CK, Rifkin DB, Janjic N. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U S A 1993;90:11227-31.
87. Green LS, Jellinek D, Jenison R, Ostman A, Heldin C-H, Janjic N. Inhibitory DNA ligands to platelet-derived growth factor B-chain. Biochemistry 1996;35:14413-24.
88. Jensen KB, Green L, MacDougal-Waugh S, Tuerk C. Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein. J Mol Blol 1994;235:237-47.
89. Schneider D, Gold L, Platt T. Selective enrichment of RNA species for tight binding to Escherichia coli rho factor. FASEB J 1993;7:201-7.
90. Nazarenko IA, Uhlenbeck OC. Defining a smaller RNA substrate for elongation factor Tu. Biochemistry 1995;34:2545-52.
91. Lochrie MA, Waugh S, Pratt DG Jr, Clever J, Parslow TG, Polisky B. In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res 1997; 25:2902-10.
92. Smith D, Kirschenheuter GP, Charlton J, Guidot DM, Repine JE. In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem Biol 1995;2:741-50.
93. + T lymphocyte function. J Immunol 1998;160:5209-12.
94. O'Connell D, Koenig A, Jennings S, Hicke B, Han H-L, Fitzwater T, et al. Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci U S A 1996;93:5883-7.
95. Bridonneau P, Chang Y-F, Buvoli V-B, O'Connell D, Parma D. Site-directed selection of oligonucleotide antagonists by competitive elution. Antisense Nucleic Acids Drug Der 1999;9:1-11.
96. Pan W, Craven RC, Qiu Q, Wilson CB, Wills JW, Golovine S, et al. Isolation of virus neutralizing RNAs from a large pool of random sequences, Proc Natl Acad Sci U S A 1995;92:11509-13.
97. Gold L. Oligonucleotides as research, diagnostic, and therapeutic agents. J Biol Chem 1995;270:13581-4.
98. Famulok M, Szostak JW. In vitro selection of specific ligand-binding nucleic acids. Angew Chem Int Ed Engl 1992;31:979-88.
99. Osborne SE, Ellington AD. Nucleic acid selection and the challenge of Combinatorial chemistry. Chem Rev 1997;97:349-70.
100. Eaton BE, Gold L, Zichi DA. Let's get specific: the relationship between specificity and affinity. Chem Biol 1995;2:633-8.
101. Griffin LC, Toole JJ, Leung LLK. The discovery and characterization of a novel nucleotide-based thrombin inhibitor. Gene 1993; 137:25-31.
102. Hicke BJ, Watson SR, Koenig A, Lynott CK, Bargatze RF, Chang Y-F, et al. DNA aptamers block L-selectin function in vivo. J Clin Investig 1996;98:2688-92.
103. Bartel DP, Szostak JW, Isolation of new ribozymes from a large pool of random sequences. Science 1993;261:1411-8.
104. Lorsch JR, Szostak JW. In vitro evolution of new ribozymes with polynucleotide kinase activity. Science 1994;371:31-6.
105. Lohse PA, Szostak JW. Ribozyme-catalysed amino-acid transfer reactions. Nature 1996;381:442-4.
106. Wilson C, Szostak JW. In vitro evolution of a self-alkylating ribozyme. Nature 1995;374:777-82.
107. Drolet DW, Moon-McDermott L, Romig TS. An enzyme-linked oligonucleotide assay. Nat Biotechnol 1996;14:1021-5.
108. Rowsell S, Stonehouse NJ, Convery MA, Adams CJ, Ellington AD, Hirao I, et al. Crystal structure of a series of RNA aptamers complexed to the same protein target. Nat Struct Biol 1998;5:970-5.
109. Jaeger J, Restle T, Steitz TA. The structure of HIV-1 reverse transcriptase complexed with RNA pseudoknot inhibitor. EMBO J 1998;17:4535-42.
110. Feigon J, Dieckmann T, Smith FW. Aptamer structure from A to ζ. Chem Biol 1996;3:611-7.
111. Patel DJ, Suri AK, Jiang F, Jiang L, Fan P, Kumar RA, et al. Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol 1997;272:645-64.
112. Zimmermann GR, Jenison RD, Wick CL, Simorre J-P, Pardi A. Interlocking structural motifs mediate molecular discrimination by a theophylline RNA. Nat Struct Biol 1997;4:644-9.
113. Hsiung C, Patel DJ. Encapsulating an amino acid in a DNA fold. Nat Struct Biol 1996;3:1046-50.
114. Yang Y, Kochoyan M, Burgstaller P, Westhof E, Famulok M. Structural basis of ligand discrimination by two related RNA aptamers resolved by NMR spectroscopy. Science 1996;272:1343-7.
115. Jiang F, Kumar RA, Jones RA, Patel DJ. Structural basis of RNA folding and recognition in an AMP-RNA aptamer complex. Nature 1996;382:183-6.
116. Fan P, Suri AK, Fiala R, Live D, Patel DJ. Molecular recognition in the FMN-RNA aptamer complex. J Mol Biol 1996;258:480-500.
117. Self CH, Dessi JL, Winger LA. High-performance assays of small molecules: enhanced sensitivity, rapidity, and convenience demonstrated with a noncompetitive immunometric anti-immune complex assay system for digoxin. Clin Chem 1994;40:2035-41.
118. Lewis JG, Manley L, Whitlow JC, Elder PA. Production of a monoclonal antibody to cortisol: application to a direct enzyme-linked immunosorbent assay of plasma. Steroids 1992;57:82-5.
119. Ghosh SK. Production of monoclonal antibodies to estriol and their application in the development of a sensitive nonisotopic immunoassay. Steroids 1988;52:1-14.
120. De Lauzon S, El Jarbi J, Desfosses B, Cittanova N. Improvement of estradiol enzymoimmunoassay, using a monoclonal antibody and an avidin/biotin amplification system. J Immunoassay 1989;10:339-57.
121. Hud E, Cohen MP. Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albumin. Clin Chim Acta 1989;185:157-64.
122. Hill CS, Wolfert RL. The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin Chim Acta 1989; 186:315-29.
123. Pettersson K, Ding Y-Q, Huhtaniemi I. Monoclonal antibody based discrepancies between two-site immunometric tests for lutropin. Clin Chem 1991;37:1745-8.
124. Pettersson KSI, Soderholm JR-M. Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies. Clin Chem 1991;37:333-40.
125. Bidart J-M, Bellet D. Human chorionic gonadotropin: molecular forms, detection and clinical implications. Trends Med 1993;4:285-90.
126. Rathnam P. Structure-function relationships of pituitary hormones HFSH, HLH, and HTSH. In: Abraham GE, ed. Radioassay systems in clinical endocrinology. New York: Marcel Dekker, 1981:21-34.
127. Wilson C, Szostak JW. Isolation of a fluorophore-specific DNA aptamer with weak radox activity. Chem Biol 1998;5:609-17.
128. Fulton RJ, McDade RL, Smith PL, Kienker LJ. Kettman JR Jr. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997;43:1749-56.
129. Davis KA, Abrams B, Lin Y, Jayasena SD. Use of a high affinity DNA ligand in flow cytometry. Nucleic Acids Res 1996;24:702-6.
130. Ringquist S, Parma D. Anti-L-Selectin oligonucleotide ligands recognize CD62L-positive Leukocytes: binding affinity and specificity of univalent and bivalent ligands. Cytometry 1998;33:394-405.
131. Stewart CC, Stewart JC. Flow cytometry part A. San Diego: Academic Press, 1994:39-60.
132. Morgan CL, Newman DJ, Price CP. Immunosensors: technology and opportunities in laboratory medicine. Clin Chem 1996;42:193-209.
133. Tom-Moy M, Baer RL, Spira-Solomon D, Doherty TP. Atrazine measurements using surface transverse wave devices. Anal Chem 1995;67:1510-6.
134. Maskos U, Southern EM. Oligonucleotide hybridisations on glass supports: a novel linker for oligonucleotide synthesis and hybridisation properties of oligonucleotides synthesised in situ. Nucleic Acids Res 1992;20:1679-84.
135. Fodor SPA, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. Site-directed spatially addressable parallel chemical synthesis. Science 1991;251:767-73.
136. Guo Z, Guilfoyle RA, Thiel AJ, Wang R, Smith LM Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports. Nucleic Acids Res 1994;22:5456-65.
137. Drmanac S, Kita D, Labat I, Hauser B, Schmidt C, Burczak JD, et al. Accurate sequencing by hybridization for diagnostics and individual genomics. Nat Biotechnol 1998;16:54-8.
138. Timofeev EN, Kochetkova SV, Mirzabekov AD, Florentiev VL. Regioselective immobilization of short oligonucleotides to acrylic copolymer gels. Nucleic Acids Res 1996;24:3142-8.
139. Herne TM, Tarlov MJ. Characterization of DNA probes immobilized on gold surfaces. J Am Chem Soc 1997;119:8916-20.
140. Kleinjung F, Klussmann S, Erdmann VA, Scheller FW, Furste JP, Bier FF. High-affinity RNA as a recognition element in a biosensor. Anal Chem 1998;70:328-31.
141. Potyrailo RA, Conrad RC, Ellington AD, Hieftje GM. Adapting selected nucleic acid ligands (aptamers) to biosensors. Anal Chem 1998;70:3419-25.
142. Holmlin RE, Dandliker PJ, Barton JK. Charge transfer through the DNA base stack. Angew Chem 1997;36:2714-30.
143. Kelly SO, Barton JK. Electron transfer between bases in double helical DNA. Science 1999;283:375-81.
144. Wilson DH, Groskopf W, Hsu S, Caplan D, Langner T, Bauman M. et al. Rapid, automated assay for progesterone on the Abbott AxSYM™ analyzer. Clin Chem 1998;44:86-91.
145. Cho J, Hamasaki K, Rando R. The binding site of a specific aminoglycoside binding RNA molecule. Biochemistry 1998;37:4985-92.
146. Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996;14:303-8.
147. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998;16:49-53.
148. Piatek AS, Tyagi S, Pol AC, Telenti A, Miller LP, Kramer FR, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998;16:359-63.
149. Koutny LB, Schmalzing D, Taylor TA, Fuchs M. Microchip electrophoretic immunoassay for serum cortisol. Anal Chem 1996;68:18-22.
150. Shimura K, Karger BL. Affinity probe capillary electrophoresis: analysis of recombinant human growth hormone with a fluorescent labeled antibody fragment. Anal Chem 1994;66:9-15.
151. Bayer EA, Wilchek M. The avidin-biotin system. In: Diamandis, EP, Christopoulos TK, eds. Immunoassay. San Diego, CA: Academic Press, 1996:237-67.
152. German I, Buchanan DD, Kennedy RT. Aptamers as ligands in affinity probe capillary electrophoresis. Anal Chem 1998;70:4540-5.
153. Lin Y, Jayasena SD. Inhibition of multiple thermostable DNA polymerases by a heterodimeric aptamer. J Mol Biol 1997;271:100-11.
154. Secher DS, Burke DC. A monoclonal antibody for large-scale purification of human leukocyte interferon. Nature 1980;285:446-8.
155. Kim HS, Smithies O. Recombinant fragment assay for gene targetting based on the polymerase chain reaction. Nucleic Acids Res 1988;16:8887-903.
156. Larzul D, Chevrier D, Guesdon JL. A non-radioactive diagnostic test for the detection of HBV DNA sequences in serum at the single molecule level. Mol Cell Probes 1989;3:45-57.
157. Chou Q, Russel M, Birch DE, Raymond J, Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res 1992;20:1717-23.
158. D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res 1991;19:3749.
159. Herbert B, Bergeron J, Potworowski EF, Tijssen P. Increased PCR sensitivity by using paraffin wax as a reaction mix overlay. Mol Cell Probes 1993;7:249-52.
160. Horton RM, Hoppe BL, Conti-Tronconi BM. Ampligrease: "hot start" PCR using petroleum jelly. Biotechniques 1994;16:42-3.
161. Li H, Cui X, Arnheim N. Direct electrophoretic detection of the allelic state of single DNA molecules in human sperm by using the polymerase chain reaction. Proc Natl Acad Sci U S A 1990;87:4580-4.
162. Kellogg DE, Rabalkin I, Chen S, Mukhamedova N, Vlasik T, Siebert PD, et al. Taq Start antibody: "hot start" PCR facilitated by a neutralizing monoclonal antibody directed against Taq polymerase. Biotechniques 1994;16:1134-7.
163. Birch DE, Kolmodlin L, Wong J, Zangenberg GA, Zocccoli MA. Simplified hot start PCR. Nature 1996;381:445-6.
164. Myers TW, Gelfand DH. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 1991;30:7661-6.
165. Tada M, Omata M, Kawai S, Saisho H, Ohto M, Saiki RK, et al. Detection of res gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
166. Sobral BW, Honeycutt RJ. High output genetic mapping of polyploids using PCR generated markers. Theor Appl Genet 1993;86:105-12.
167. Ceo Y, Suresh MR. Bispecific antibodies as novel bioconjugates. Bioconjug Chem 1998;9:635-44.
168. Miller PS, Bham P, Kan L-S. Synthesis and interaction of oligodeoxyribonucleotides containing 2′-amino-2′-deoxyuridine. Nucleosides Nucleotides 1993;12:785-92.
169. Lin Y, Nieuwlandt D, Magallanez A, Feistner B, Jayasena SD. High-affinity and specific recognition of human thyroid stimulating hormone (hTSH) Dy in vitro selected 2'-amino-modified RNA. Nucleic Acids Res 1996;24:3407-14.
170. Gold L, Jayasena SD, Nieuwlandt D, Davis K, inventors. High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones. US patent 5,837,456, 1998.
171. Lapthorn AJ, Harris DC, Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, et al. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-61.
172. Bottger V, Micheel B, Scharte G, Kaiser G, Wolf G, Schmechta H. Monoclonal antibodies to human chorionic gonadotropin (HCG) and their use in two-site binding enzyme immunoassays. Hybridoma 1993;12:81-91.
173. Griffin J, Odell WD. Ultrasensitive immunoradiometric assay for chorionic gonadotropin which does not cross-react with luteinizing hormone nor free β chain of hCG and which detects hCG in blood of non-pregnant humans. J Immunol Methods 1987;103:275-83.
174. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992;267:26031-7.
175. DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 1997;278:680-6.
176. Dove A. Proteomics: translating genomics into products? Nat Biotechnol 1999;17:233-6.
177. Milligan JF, Groebe DR, Witherell GW, Uhlenbeck OC. Oligoribo-nucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 1987;15:8783-98.
178. Cadwell RC, Joyce GF. Randomization of genes by PCR mutagenesis. PCR Methods Appl 1992;2:28-33.
179. Zaccolo M, Williams DM, Brown DM, Gherardi E. An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol 1996;255:589-603.
180. Vartanian J-P, Henry M, Wain-Hobson S. Hypermutagenic PCR involving all four transitions and a sizable proportion of transversions. Nucleic Acids Res 1996;24:2627-31.
181. Nilsson J, Bosnes M, Larsen F, Nygen P-A, Uhlen M, Lundeberg J. Heat-mediated activation of affinity-immobilized Taq DNA polymerase. Biotechniques 1997;22:744-51.